Search Results

There are 2278079 results for: content related to: Efficacy, predictors of response, and potential risks associated with antiviral therapy in liver transplant recipients with recurrent hepatitis C

  1. You have free access to this content
    Poster Session 2: Hepatitis C: Therapeutics (Approved Agents)

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 714A–807A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28228

  2. You have free access to this content
    HCV Therapeutics: Approved Agents

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 1091A–1168A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26880

  3. You have free access to this content
    Poster Session 2: Hepatitis C: Approved Therapeutic Agents

    Hepatology

    Volume 60, Issue S1, October 2014, Pages: 659A–709A,

    Version of Record online : 1 OCT 2014, DOI: 10.1002/hep.27516

  4. You have free access to this content
    Diagnosis, management, and treatment of hepatitis C: An update

    Hepatology

    Volume 49, Issue 4, April 2009, Pages: 1335–1374, Marc G. Ghany, Doris B. Strader, David L. Thomas and Leonard B. Seeff

    Version of Record online : 2 DEC 2008, DOI: 10.1002/hep.22759

  5. Hepatitis C

    Standard Article

    Wiley Handbook of Current and Emerging Drug Therapies

    Published Online : 15 SEP 2006, DOI: 10.1002/9780470041000.cedt033

  6. You have free access to this content
    Excess liver-related morbidity of chronic hepatitis C patients, who achieve a sustained viral response, and are discharged from care

    Hepatology

    Volume 54, Issue 5, November 2011, Pages: 1547–1558, Hamish A. Innes, Sharon J. Hutchinson, Samuel Allen, Diptendu Bhattacharyya, Peter Bramley, Toby E.S. Delahooke, John F. Dillon, Ewan Forrest, Andrew Fraser, Ruth Gillespie, David J. Goldberg, Nicholas Kennedy, Scott McDonald, Allan McLeod, Peter R. Mills, Judith Morris, Peter Hayes and on behalf of the Hepatitis C Clinical Database Monitoring Committee.

    Version of Record online : 28 OCT 2011, DOI: 10.1002/hep.24561

  7. You have free access to this content
    Poster Session 4: Acute Liver Failure and Artificial Liver Support; Diagnostics, Epidemiology, and Natural History

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 1064A–1132A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28236

  8. The cost of treatment failure: resource use and costs incurred by hepatitis C virus genotype 1–infected patients who do or do not achieve sustained virological response to therapy

    Journal of Viral Hepatitis

    Volume 21, Issue 3, March 2014, Pages: 208–215, M. Backx, A. Lewszuk, J. R. White, J. Cole, A. Sreedharan, S. van Sanden, J. Diels, A. Lawson, K. R. Neal, M. J. Wiselka, T. Ito and W. L. Irving

    Version of Record online : 1 AUG 2013, DOI: 10.1111/jvh.12132

  9. You have free access to this content
    Sequence variation in hepatitis C virus nonstructural protein 5A predicts clinical outcome of pegylated interferon/ribavirin combination therapy

    Hepatology

    Volume 48, Issue 1, July 2008, Pages: 38–47, Ahmed El-Shamy, Motoko Nagano-Fujii, Noriko Sasase, Susumu Imoto, Soo-Ryang Kim and Hak Hotta

    Version of Record online : 24 MAR 2008, DOI: 10.1002/hep.22339

  10. Prediction of human cytochrome P450 2B6-substrate interactions using hierarchical support vector regression approach

    Journal of Computational Chemistry

    Volume 30, Issue 12, September 2009, Pages: 1899–1909, Max K. Leong, Yen-Ming Chen and Tzu-Hsien Chen

    Version of Record online : 29 DEC 2008, DOI: 10.1002/jcc.21190

  11. You have free access to this content
    A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis

    Hepatology

    Volume 56, Issue 2, August 2012, Pages: 532–543, Roberta D'Ambrosio, Alessio Aghemo, Maria Grazia Rumi, Guido Ronchi, Maria Francesca Donato, Valerie Paradis, Massimo Colombo and Pierre Bedossa

    Version of Record online : 2 JUL 2012, DOI: 10.1002/hep.25606

  12. Process modeling and optimization of industrial ethylene oxide reactor by integrating support vector regression and genetic algorithm

    The Canadian Journal of Chemical Engineering

    Volume 87, Issue 1, February 2009, Pages: 118–128, Sandip Kumar Lahiri and Nadeem Khalfe

    Version of Record online : 25 FEB 2009, DOI: 10.1002/cjce.20123

  13. Sustained virological response of patients with hepatitis C virus genotype 2 depends on pegylated interferon compliance

    Hepatology Research

    Volume 41, Issue 8, August 2011, Pages: 722–730, Takao Watanabe, Ichiro Konishi, Shuichiro Shigematsu, Kazuhiro Uesugi, Kouji Joko, Hirotaka Seike, Shinichi Okada, Hiroaki Miyaoka, Seiji Nakanishi, Masanori Abe, Bunzo Matsuura, Kojiro Michitaka, Norio Horiike, Yoichi Hiasa and Morikazu Onji

    Version of Record online : 17 JUN 2011, DOI: 10.1111/j.1872-034X.2011.00816.x

  14. The Role of Pharmacogenetics in the Treatment of Chronic Hepatitis C Infection

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 34, Issue 2, February 2014, Pages: 185–201, Marina Kawaguchi-Suzuki and Reginald F. Frye

    Version of Record online : 30 SEP 2013, DOI: 10.1002/phar.1349

  15. Novel soft sensor modeling and process optimization technique for commercial petrochemical plant

    Asia-Pacific Journal of Chemical Engineering

    Volume 5, Issue 5, September/October 2010, Pages: 721–731, S. K. Lahiri and Nadeem M. Khalfe

    Version of Record online : 20 OCT 2009, DOI: 10.1002/apj.399

  16. Multivariate lesion-symptom mapping using support vector regression

    Human Brain Mapping

    Volume 35, Issue 12, December 2014, Pages: 5861–5876, Yongsheng Zhang, Daniel Y. Kimberg, H. Branch Coslett, Myrna F. Schwartz and Ze Wang

    Version of Record online : 15 JUL 2014, DOI: 10.1002/hbm.22590

  17. Effect of peginterferon alfa-2b and ribavirin on hepatocellular carcinoma prevention in older patients with chronic hepatitis C

    Journal of Gastroenterology and Hepatology

    Volume 30, Issue 2, February 2015, Pages: 321–328, Takashi Honda, Masatoshi Ishigami, Hiroko Masuda, Yoji Ishizu, Teiji Kuzuya, Kazuhiko Hayashi, Akihiro Itoh, Yoshiki Hirooka, Isao Nakano, Tetsuya Ishikawa, Fumihiro Urano, Kentaro Yoshioka, Hidenori Toyoda, Takashi Kumada, Yoshiaki Katano and Hidemi Goto

    Version of Record online : 24 JAN 2015, DOI: 10.1111/jgh.12703

  18. You have free access to this content
    A 48-week telaprevir-based triple combination therapy improves sustained virological response rate in previous non-responders to peginterferon and ribavirin with genotype 1b chronic hepatitis C: A multicenter study

    Hepatology Research

    Volume 44, Issue 14, December 2014, Pages: E386–E396, Noritomo Shimada, Akihito Tsubota, Masanori Atsukawa, Hiroshi Abe, Tatsuya Ide, Koichi Takaguchi, Yoshimichi Chuganji, Hidenori Toyoda, Kai Yoshizawa, Makiko Ika, Yoshiyuki Sato, Keizo Kato, Takashi Kumada, Choitsu Sakamoto, Yoshio Aizawa and Michio Sata

    Version of Record online : 15 APR 2014, DOI: 10.1111/hepr.12323

  19. Clinical utility of host genetic IL-28B variants in hepatitis C virus genotype 1 Asian patients retreated with pegylated interferon plus ribavirin

    Journal of Gastroenterology and Hepatology

    Volume 28, Issue 9, September 2013, Pages: 1515–1520, Chung-Feng Huang, Ming-Lun Yeh, Meng-Hsuan Hsieh, Ming-Yen Hsieh, Zu-Yau Lin, Shinn-Cherng Chen, Liang-Yen Wang, Jee-Fu Huang, Suh-Hang Hank Juo, Yi-Ching Lin, Chia-Yen Dai, Wan-Long Chuang and Ming-Lung Yu

    Version of Record online : 22 AUG 2013, DOI: 10.1111/jgh.12211

  20. You have free access to this content
    Poster Session 4: Hepatitis C: New Agents (Not Approved)

    Hepatology

    Volume 60, Issue S1, October 2014, Pages: 1128A–1161A,

    Version of Record online : 1 OCT 2014, DOI: 10.1002/hep.27533